Norwegian Cruise Line Holdings Ltd. Announces Pricing of 47,577,947 Ordinary Shares

MIAMI, March 05, 2021 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) announced today that it has priced its underwritten public offering of 47,577,947 ordinary shares of the Company (the “Offering”) at a price to the public of $30.00 per share. The Company has granted the underwriter an option to purchase up to 5,000,000 additional ordinary shares.

The Offering is expected to close on March 9, 2021, subject to customary closing conditions. The Company expects to use the net proceeds from the Offering to repurchase all of NCL Corporation Ltd.’s, a subsidiary of the Company, exchangeable senior notes due 2026, which are currently held by an affiliate of L Catterton, with any remaining net proceeds to be used for general corporate purposes.

Goldman Sachs & Co. LLC is acting as sole underwriter for the Offering.

The Offering is being made under an automatic shelf registration statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 17, 2020. The Offering may be made only by means of a prospectus supplement and an accompanying base prospectus. A preliminary prospectus supplement and accompanying base prospectus relating to the Offering have been filed, and a final prospectus supplement will be filed, with the SEC and will be available on the SEC’s website at www.sec.gov, copies of which may be obtained by contacting Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration and qualification under the securities laws of such state or jurisdiction.

About Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 28 ships with approximately 59,150 berths, these brands offer itineraries to more than 490 destinations worldwide. The Company has nine additional ships scheduled for delivery through 2027.

Cautionary Statement Concerning Forward-Looking Statements

Some of the statements, estimates or projections contained in this press release are “forward-looking statements” within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release, including, without limitation, those regarding our business strategy, financial position, results of operations, plans, prospects, actions taken or strategies being considered with respect to our liquidity position, valuation and appraisals of our assets and objectives of management for future operations (including those regarding expected fleet additions, our voluntary suspension, our ability to weather the impacts of the novel coronavirus (“COVID-19”) pandemic, our expectations regarding the resumption of cruise voyages and the timing for such resumption of cruise voyages, the implementation of and effectiveness of our health and safety protocols, operational position, demand for voyages, financing opportunities and extensions, and future cost mitigation and cash conservation efforts and efforts to reduce operating expenses and capital expenditures) are forward-looking statements. Many, but not all, of these statements can be found by looking for words like “expect,” “anticipate,” “goal,” “project,” “plan,” “believe,” “seek,” “will,” “may,” “forecast,” “estimate,” “intend,” “future” and similar words. Forward-looking statements do not guarantee future performance and may involve risks, uncertainties and other factors which could cause our actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Examples of these risks, uncertainties and other factors include, but are not limited to the impact of:

  • the spread of epidemics, pandemics and viral outbreaks and specifically, the COVID-19 pandemic, including its effect on the ability or desire of people to travel (including on cruises), which are expected to continue to adversely impact our results, operations, outlook, plans, goals, growth, reputation, cash flows, liquidity, demand for voyages and share price;
  • our ability to comply with the U.S. Centers for Disease Control and Prevention (“CDC”) Framework for Conditional Sailing Order and any additional or future regulatory restrictions on our operations and to otherwise develop enhanced health and safety protocols to adapt to the pandemic’s unique challenges once operations resume and to otherwise safely resume our operations when conditions allow;
  • coordination and cooperation with the CDC, the federal government and global public health authorities to take precautions to protect the health, safety and security of guests, crew and the communities visited and the implementation of any such precautions;
  • our ability to work with lenders and others or otherwise pursue options to defer, renegotiate or refinance our existing debt profile, near-term debt amortization, newbuild related payments and other obligations and to work with credit card processors to satisfy current or potential future demands for collateral on cash advanced from customers relating to future cruises;
  • our future need for additional financing, which may not be available on favorable terms, or at all, and may be dilutive to existing shareholders;
  • our indebtedness and restrictions in the agreements governing our indebtedness that require us to maintain minimum levels of liquidity and otherwise limit our flexibility in operating our business, including the significant portion of assets that are collateral under these agreements;
  • the accuracy of any appraisals of our assets as a result of the impact of COVID-19 or otherwise;
  • our success in reducing operating expenses and capital expenditures and the impact of any such reductions;
  • our guests’ election to take cash refunds in lieu of future cruise credits or the continuation of any trends relating to such election;
  • trends in, or changes to, future bookings and our ability to take future reservations and receive deposits related thereto;
  • the unavailability of ports of call;
  • future increases in the price of, or major changes or reduction in, commercial airline services;
  • adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events;
  • adverse incidents involving cruise ships;
  • adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence;
  • any further impairment of our trademarks, trade names or goodwill;
  • breaches in data security or other disturbances to our information technology and other networks or our actual or perceived failure to comply with requirements regarding data privacy and protection;
  • changes in fuel prices and the type of fuel we are permitted to use and/or other cruise operating costs;
  • mechanical malfunctions and repairs, delays in our shipbuilding program, maintenance and refurbishments and the consolidation of qualified shipyard facilities;
  • the risks and increased costs associated with operating internationally;
  • fluctuations in foreign currency exchange rates;
  • overcapacity in key markets or globally;
  • our expansion into and investments in new markets;
  • our inability to obtain adequate insurance coverage;
  • pending or threatened litigation, investigations and enforcement actions;
  • volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees;
  • our inability to recruit or retain qualified personnel or the loss of key personnel or employee relations issues;
  • our reliance on third parties to provide hotel management services for certain ships and certain other services;
  • our inability to keep pace with developments in technology;
  • changes involving the tax and environmental regulatory regimes in which we operate; and
  • other factors set forth under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 26, 2021.

Additionally, many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 pandemic. It is not possible to predict or identify all such risks. There may be additional risks that we consider immaterial or which are unknown.

The above examples are not exhaustive and new risks emerge from time to time. Such forward-looking statements are based on our current beliefs, assumptions, expectations, estimates and projections regarding our present and future business strategies and the environment in which we expect to operate in the future. These forward-looking statements speak only as of the date made.

We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained herein to reflect any change in our expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based, except as required by law.

Investor Relations & Media Contact

Andrea DeMarco
(305) 468-2339
[email protected]

Jessica John
(786) 913-2902



Compass Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Compass Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

BOSTON–(BUSINESS WIRE)–
Compass Therapeutics, Inc. (OTCQB: CMPX), a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies, today reported fourth quarter and full year 2020 financial results and provided a business update.

“2020 was a transformational year for Compass,” said Thomas J. Schuetz, M.D., Ph.D., co-founder and chief executive officer. “We initiated the dose expansion stage (Phase 1b) of our Phase 1 study for our lead product candidate CTX-471 (CD137 agonist) in September after successfully completing the dose escalation stage of the study in July. Importantly, among the six evaluable patients in the dose expansion stage of the study, who have reached their week 9 evaluation, five patients had stable disease. Subsequently, one of those patients who has advanced small cell lung cancer had a partial response (PR) at week 17. In addition, in the dose escalation stage of the study (Phase 1a) we reported a patient with melanoma of mucosal origin who had a 24% decline in his linear tumor burden. These early signs of anti-tumor activity are encouraging, and we look forward to receiving more CTX-471 data as the study progresses. Top-line data from the Phase 1b stage of the study is expected in the second half of the year, and we could initiate a Phase 2/3 study in the second half of 2022.

“On the financing side, we completed a $60M private placement and became a public reporting company in June 2020. We also recently announced that our common stock has been cleared for trading on the OTCQB tier of the OTC market. These events represent significant achievements for the company as we continue to build the infrastructure to support the future growth of Compass.”

Development Pipeline Update and Highlights:

CTX-471, a CD137 Agonist monoclonal antibody:

  • Completed CTX-471 Phase 1a dose escalation study and found CTX-471 to be generally well-tolerated
  • Initiated CTX-471 Phase 1b dose expansion study and treated 11 patients in the study as of February 28, 2021
  • Of the six evaluable patients in the dose expansion part of the study, five patients with advanced solid tumors who have reached their week 9 evaluation had stable disease. Additionally, a patient with advanced small cell lung cancer had a PR at week 17 of the study
  • Data published in the peer-reviewed Journal of Clinical Investigation Insight (JCI Insight) demonstrated the preclinical monotherapy activity and safety of CTX-471 across various syngeneic tumor models

CTX-8371, a PD-1 X PD-L1 Bispecific:

  • Initiated IND-enabling studies and the GMP manufacturing campaign
  • Generated preclinical data that demonstrated the differentiation between CTX-8371 and commercially available single PD-1 blockers, single PD-L1 blockers or combinations of PD-1 and PD-L1 blockers
  • Initiated preparation of IND submission materials with the goal of submission of the IND in early 2022 and potential for early safety and top-line data later in 2022

Financial Highlights:

  • Completed $60.5M in gross proceeds ($54.2M net of expenses) private placement financing in combination with reverse merger with a public shell that transitioned the company to a public company and enabled listing of the company stock on the OTC market under the symbol “CMPX”
  • Established public company reporting process including internal controls over financial reporting

Other Business Updates:

  • Promoted Vered Bisker-Leib, Ph.D., to Chief Operating Officer in January and President and COO in July
  • Strengthened our board with the addition of Brett Kaplan as an independent board member and chair of the audit committee of the board and audit committee financial expert
  • Published preclinical data in the journal Science supporting the potential of CTX-2026, a novel antibody to the butyrophilin BTN3A1 in ovarian cancer tumor models
  • Based on a review of our pipeline, made a strategic decision to deprioritize the development of our NKp30 innate cell engager platform and discontinued efforts to advance CTX-8573 to IND-enabling studies
  • Entered into a new lease agreement for our lab and office space and relocated our operations to 80 Guest Street, Boston, MA

Financial Results for Fourth Quarter and Full Year Ended December 31, 2020

Net loss for the full year 2020 was $29.5 million or $0.96 per common share, compared to $34.7 million or $5.19 per common share for the full year 2019. Net loss for the fourth quarter of 2020 was $8.4 million or $0.16 per common share, compared to $6.6 million or $0.95 per common share in the fourth quarter of 2019.

Research and development (R&D) Expenses

R&D expenses were $14.9 million for the full year of 2020, as compared to $22.4 million for the same period in 2019, a reduction of $7.5 million or 34%. The lower costs were principally driven by a strategic reduction in head count and the completion of preclinical efforts for CTX-471. R&D expenses were $4.4 million during the fourth quarter of 2020, as compared to $3.3 million for the same period in 2019, an increase of $1.1 million or 33%. The higher costs were primarily related to manufacturing expenses and toxicological studies for CTX-8371.

General and Administrative (G&A) Expenses

G&A expenses were $12.9 million for the full year 2020, as compared to $11.6 million for the same period in 2019, an increase of $1.3 million or 11%. The higher costs were principally driven by an increase in stock-based compensation expenses and costs associated with the transition of the company from private to public. G&A expenses were $3.5 million during the fourth quarter of 2020, as compared to $3.1 million for the same period in 2019, an increase of $0.4 million or 14%. The higher costs were driven by higher stock-based compensation expenses.

Cash Position

As of December 31, 2020, cash and cash equivalents were $47.1 million as compared to $25.3 million as of December 31, 2019, providing the Company with an anticipated cash runway into the second quarter of 2022. During 2020, the Company increased its cash position through proceeds from financing activities of $48.5 million, primarily from $54.2 million of net proceeds from issuance of common stock, partially offset with loan payments of $5.6 million. The Company used $26.8 million of cash to fund operations.

About Compass Therapeutics

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain based multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. The Company’s lead product candidate, CTX-471, is a fully human agonistic antibody of CD137, and is currently being evaluated in a Phase 1b study. The Company’s offices and labs are located in Boston, MA. Visit website at www.compasstherapeutics.com

Forward-Looking Statements

This press release contains forward-looking statements. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to the Company’s financial position to continue advancing its product candidates, expectations about the Company’s cash runway, our product candidates and the development and therapeutic potential thereof, our technologies for identifying additional product candidates, and our business and development plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, the inherent uncertainties associated with developing product candidates and operating as a development stage company, our ability to identify additional product candidates for development, our ability to develop, complete clinical trials for, obtain approvals for and commercialize any of our product candidates, and competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this press release, and Compass assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents we file with the SEC available at www.sec.gov, including without limitation our Form 10-K for the year ended December 31, 2020, and our subsequent filings with the SEC.

 

Compass Therapeutics, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

Three Months Ended

 

Year Ended

December 31,

 

December 31,

2020

 

2019

 

2020

 

2019

Operating expenses:
Research and development

$

4,406

 

$

3,303

 

$

14,904

 

$

22,449

 

General and administrative

 

3,544

 

 

3,099

 

 

12,908

 

 

11,603

 

Loss from operations

 

(7,950

)

 

(6,402

)

 

(27,812

)

 

(34,052

)

Total other income (expense)

 

(441

)

 

(200

)

 

(1,656

)

 

(601

)

Income tax expense

 

 

 

(10

)

 

(32

)

 

(91

)

Net loss

$

(8,391

)

$

(6,612

)

$

(29,500

)

$

(34,744

)

 
Basic and diluted EPS

($0.16

)

($0.95

)

($0.96

)

($5.19

)

Weighted average shares outstanding

 

51,052

 

 

6,956

 

 

30,776

 

 

6,691

 

 

Compass Therapeutics, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

 

December 31,

 

 

2020

 

2019

Cash and cash equivalents

$

47,076

$

25,303

 

Total assets

 

51,911

 

30,381

 

Total debt

 

9,334

 

14,869

 

Total Liabilities

 

11,966

 

19,114

 

Total stockholders’ equity (deficit)

 

39,945

 

(118,603

)

 

Investor Contact

Vered Bisker-Leib, President & Chief Operating Officer

[email protected]

Media Contact

[email protected]

617-500-8099

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Oncology Health Infectious Diseases General Health Pharmaceutical Biotechnology

MEDIA:

Logo
Logo

Performance Shipping Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020

ATHENS, Greece, March 05, 2021 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (the “Company”), a global shipping company specializing in the ownership of tanker vessels, today reported a net loss and net loss from continuing and discontinued operations attributable to common stockholders of $2.5 million for the fourth quarter of 2020, compared to a net loss and net loss from continuing and discontinued operations attributable to common stockholders of $12.2 million for the same period in 2019. Loss per share for the fourth quarter of 2020 was $0.51, while loss per share for the fourth quarter of 2019 was $3.17.

Voyage and time charter revenues from continuing and discontinued operations were $7.2 million ($3.9 million net of voyage expenses) for the fourth quarter of 2020, compared to $10.6 million ($8.5 million net of voyage expenses) for the same period in 2019. This decrease was mainly attributable to the decreased time-charter equivalent rates (TCE rates) achieved during the quarter as a result of the depressed market conditions. Fleetwide, the average time charter equivalent rate for the fourth quarter of 2020 was $10,114, compared with an average rate of $23,153 for the same period of 2019. During the fourth quarter of 2020, net cash provided by operating activities of continuing and discontinued operations was $0.9 million, compared with net cash used in operating activities of continuing and discontinued operations of $0.3 million for the fourth quarter of 2019.

Net income from continuing and discontinued operations for the year ended December 31, 2020, amounted to $3.8 million, compared to a net loss from continuing and discontinued operations of $32.1 million for the year ended December 31, 2019. Net income from continuing and discontinued operations attributable to common stockholders for the year ended December 31, 2020, amounted to $5.2 million, due to a one-time gain of $1.5 million derived from the repurchase of the Series C preferred shares, and resulted in earnings per common share, basic and diluted, of $1.06 and $1.05, respectively. Net loss from continuing and discontinued operations attributable to common stockholders for the year ended December 31, 2019, was $32.1 million, resulting in a loss per share of $11.19.


Fourth Quarter 2020 and Subsequent Developments:

  • Appointment of Andreas Michalopoulos as Chief Executive Officer and Anthony Argyropoulos as Chief Financial Officer in October 2020;
  • Initiation of new variable quarterly dividend policy and declaration of $0.01 dividend per share (or $0.1 per share, as adjusted after the one-for-ten reverse stock split) to all shareholders in October 2020;
  • Introduction of new business strategy and posting of the relevant presentation on the Company’s website in October 2020;
  • Effectiveness of a one-for-ten reverse stock split to comply with NASDAQ’s minimum share price rule in November 2020;
  • Acquisition of 2011-built Aframax tanker vessel “P. Yanbu” for $22.0 million in November 2020;
  • The signing of a loan agreement with Piraeus Bank S.A. for up to $31.5 million in December 2020, for the partial refinancing of the existing Nordea loan and additional financing for the “P. Yanbu”;
  • Signing of a supplemental loan agreement with Nordea for repayment schedule re-structuring in December 2020;
  • Delivery of the Aframax tanker vessel “P. Yanbu” in December 2020;
  • Entry into an At-The-Market Offering Agreement with H.C. Wainwright Co., LLC, pursuant to which the Company may, at its discretion, sell its common shares at market prices.

Commenting on the results of the fourth quarter of 2020, Mr. Andreas Michalopoulos, the Company’s Chief Executive Officer, stated:

“Spot charter rates during the fourth quarter of 2020 were the lowest in more than 30 years as a result of a combination of weak consumer and industrial demand, and low crude oil and refined petroleum products production. We, at Performance Shipping Inc., nevertheless managed to earn a time charter equivalent rate of $10,114 over our available days compared to the average daily spot Aframax tanker rate of $5,713 during the quarter. We expect the spot charter market to gradually recover through 2021 as the COVID-19 pandemic recedes and demand for crude oil and refined petroleum products recovers. Unfortunately, due to unprecedented low market conditions, we cannot declare and pay a dividend at the present time, but we are pleased to include for the first time in our earnings release our fourth quarter dividend calculation, a specific and transparent table based on which we determine whether we shall pay a dividend. The ATM agreement we will enter into today will position us to fund our stated growth strategy of gradually doubling the size of our fleet over the next twelve to twenty-four months through access to the public equity capital markets when our industry and share price recover in the future.”


Tanker Market Update:

  • Fleet supply was 641.0 million dwt, up 0.3% from 638.9 million dwt from the previous quarter, and up 3.0% from Q4 2019 levels of 622.3 million dwt.
  • Demand is estimated to have increased by 2.0% from the previous quarter and 12.5% from Q4 2019 levels.
  • Crude tanker fleet utilization was estimated at 79.6%, down from 84.5% from the previous quarter and down from Q4 2019 levels of 89.3%.
  • Newbuilding contracting at 9.3 million dwt resulted in a further reduction of the orderbook to 7.7% of the fleet, the lowest level since 1996.
  • Daily spot charter rates for Aframax tankers averaged $5,713, down 34.3% from the previous quarter average of $8,698 and down 89.0% from Q4 2019 average of $52,853.
  • The value of a 10-year-old Aframax tanker ended the quarter at $20.5 million, down 10.9% from the previous quarter assessed value of $23 million, and down 31.7% from Q4 2019 assessed value of $30 million.
  • Tankers used for floating storage (excluding dedicated storage) was 232 (38.3 million dwt), down 29.9% from 331 (47.6 million dwt) from the previous quarter and up 231.4% from Q4 2019 levels of 70 (16.5 million dwt).
  • Global oil consumption was 95.5 million bpd, up 2.3% from the previous quarter level of 93.4 million bpd, and down 6.1% from Q4 2019 levels of 101.7 million bpd.
  • Global oil production was 92.3 million bpd, up 1.2% from the previous quarter level of 91.2 million bpd and down 9.1% from Q4 2019 levels of 101.6 million bpd.
  • OECD commercial inventories were 3,045.2 million barrels, down 3.9% from the previous quarter level of 3,168.9 million barrels, and up 5.8% from Q4 2019 levels of 2,878.8 million barrels.


Novel Coronavirus Risks:

On March 11, 2020, the World Health Organization declared the novel coronavirus (“COVID-19”) outbreak a pandemic. In response to the outbreak, many countries, ports and organizations, including those where the Company conducts a large part of its operations, have implemented measures to combat the outbreak, such as quarantines, travel restrictions, and other emergency public health measures in an effort to contain the outbreak. Such measures have resulted in a significant reduction in global economic activity and extreme volatility in the global financial markets, which has reduced the global demand for oil and oil products, which the Company’s vessels transport. The extent to which COVID-19 will impact the Company’s results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the virus and the actions to contain or treat its impact, among others. Accordingly, an estimate of the impact cannot be made at this time. However, if the COVID-19 pandemic worsens, additional restrictions are imposed, or current restrictions are imposed for a longer period of time in response to the outbreak, the adverse impact on the global economy and the rate environment for tankers may deteriorate further, which may result in a material adverse effect on the Company’s business, results of operations, cash flows, financial condition, vessel values, and ability to pay dividends.

 
Summary of Selected Financial & Other Data
      For the three months ended December 31,   For the years ended December 31,
      2020     2019     2020     2019  
      (unaudited)   (unaudited)   (unaudited)   (unaudited)
STATEMENT OF OPERATIONS DATA (in thousands of US Dollars):

CONTINUING AND DISCONTINUED OPERATIONS
           
  Voyage and time charter revenues $ 7,205   $ 10,580   $ 46,283   $ 26,846  
  Voyage expenses   3,311     2,083     14,622     3,447  
  Vessel operating expenses   2,412     2,605     11,544     11,321  
  Net income / (loss)   (2,548 )   (12,228 )   3,777     (32,057 )
  Net income / (loss) attributable to common stockholders   (2,548 )   (12,228 )   5,190     (32,057 )
  Earnings / (Loss) per common share, basic   (0.51 )   (3.17 )   1.06     (11.19 )
  Earnings / (Loss) per common share, diluted   (0.51 )   (3.17 )   1.05     (11.19 )
FLEET DATA
  Average number of vessels   4.2     4.0     4.6     4.2  
  Number of vessels   5.0     4.0     5.0     4.0  
  Ownership days   385     367     1,689     1,516  
  Available days   385     367     1,689     1,516  
  Operating days, excluding ballast leg (1)   254     330     1,258     1,401  
  Operating days, including ballast leg (2)   321     351     1,515     1,422  
  Fleet utilization, excluding ballast leg   66.0%     89.9%     74.5%     92.4%  
  Fleet utilization, including ballast leg   83.4%     95.6%     89.7%     93.8%  
AVERAGE DAILY RESULTS
  Time charter equivalent (TCE) rate (3) $ 10,114   $ 23,153   $ 18,745   $ 15,435  
  Daily vessel operating expenses (4) $ 6,265   $ 7,098   $ 6,835   $ 7,468  
                   

           
      For the three months ended December 31,   For the years ended December 31,
      2020     2019     2020     2019  
      (unaudited)   (unaudited)   (unaudited)   (unaudited)
STATEMENT OF OPERATIONS DATA (in thousands of US Dollars):

CONTINUING OPERATIONS
               
  Voyage and time charter revenues $ 7,205   $ 5,050   $ 42,045   $ 6,301  
  Voyage expenses   3,311     1,928     14,434     2,460  
  Vessel operating expenses   2,412     800     9,208     1,122  
  Net income / (loss)   (2,548 )   (1,371 )   2,295     (6,743 )
  Net income / (loss) attributable to common stockholders   (2,548 )   (1,371 )   3,708     (6,743 )
  Earnings / (Loss) per common share, basic   (0.51 )   (0.35 )   0.76     (2.35 )
  Earnings / (Loss) per common share, diluted   (0.51 )   (0.35 )   0.75     (2.35 )
FLEET DATA
  Average number of vessels   4.2     1.4     3.7     0.5  
  Number of vessels   5.0     2.0     5.0     2.0  
  Ownership days   385     132     1,365     188  
  Available days   385     132     1,365     188  
  Operating days, excluding ballast leg (1)   254     102     945     138  
  Operating days, including ballast leg (2)   321     123     1,202     159  
  Fleet utilization, excluding ballast leg   66.0%     77.3%     69.2%     73.4%  
  Fleet utilization, including ballast leg   83.4%     93.2%     88.1%     84.6%  
AVERAGE DAILY RESULTS
  Time charter equivalent (TCE) rate (3) $ 10,114   $ 23,652   $ 20,228   $ 20,431  
  Daily vessel operating expenses (4) $ 6,265   $ 6,061   $ 6,746   $ 5,968  
                   

DISCONTINUED OPERATIONS (5)
               
  Time charter revenues $   $ 5,530   $ 4,238   $ 20,545  
  Voyage expenses       155     188     987  
  Vessel operating expenses       1,805     2,336     10,199  
  Net income / (loss)       (10,857 )   1,482     (25,314 )
  Net income / (loss) attributable to common stockholders       (10,857 )   1,482     (25,314 )
  Earnings / (Loss) per common share, basic       (2.82 )   0.30     (8.84 )
  Earnings / (Loss) per common share, diluted       (2.82 )   0.30     (8.84 )
FLEET DATA
  Average number of vessels       2.6     0.9     3.6  
  Number of vessels       2.0         2.0  
  Ownership days       235     324     1,328  
  Available days       235     324     1,328  
  Operating days       228     313     1,263  
  Fleet utilization       97.0%     96.6%     95.1%  
AVERAGE DAILY RESULTS
  Time charter equivalent (TCE) rate (3) $   $ 22,872   $ 12,500   $ 14,727  
  Daily vessel operating expenses (4) $   $ 7,681   $ 7,210   $ 7,680  
                           

________________________
(1) Operating days, excluding ballast leg, are the number of available days in a period less the aggregate number of days that our vessels are off-hire. The specific calculation counts the ballast leg of spot voyages as off-hire days, even if a charter party exists, so as to be in line with the accounting guidelines of ASC 606 for the revenue recognition (“loading” to “discharging” accounting). The shipping industry uses operating days to measure the aggregate number of days in a period during which vessels actually generate revenues.
(2) Operating days, including ballast leg, are the number of available days in a period less the aggregate number of days that our vessels are off-hire. The specific calculation does not count as off-hire the days of the ballast leg of the spot voyages, as long as a charter party is in place. The shipping industry uses operating days to measure the aggregate number of days in a period during which vessels actually generate revenues.
(3) Time charter equivalent rates, or TCE rates, are defined as our voyage and time charter revenues, less voyage expenses during a period divided by the number of our available days during the period, which is consistent with industry standards. Voyage expenses include port charges, bunker (fuel) expenses, canal charges and commissions. TCE is a non-GAAP measure. TCE rate is a standard shipping industry performance measure used primarily to compare daily earnings generated by vessels despite changes in the mix of charter types (i.e., voyage (spot) charters, time charters and bareboat charters).
(4) Daily vessel operating expenses, which include crew wages and related costs, the cost of insurance and vessel registry, expenses relating to repairs and maintenance, the costs of spares and consumable stores, lubricant costs, tonnage taxes, regulatory fees, environmental costs, lay-up expenses and other miscellaneous expenses, are calculated by dividing vessel operating expenses by ownership days for the relevant period.
(5) Discontinued Operations refer to our container vessels segment.

 
Fleet Employment Profile (As of March [5], 2021)
Performance Shipping Inc.’s fleet is employed as follows:
                   
  Vessel
Year of
Built

Capacity
Builder
Gross Rate
(USD Per
Day)



Com*
Charterers
Delivery Date to
Charterers

Redelivery Date to
Owners**

  4 Aframax Tanker Vessels


1 BLUE MOON 2011 104,623 DWT Sumitomo Heavy Industries Marine & Engineering Co., LTD. $28,000 5.00% Aramco Trading Company, Saudi Arabia 19-Jun-20 19-Nov-21 – 18-Jan-22
2 BRIOLETTE 2011 104,588 DWT Sumitomo Heavy Industries Marine & Engineering Co., LTD. Spot – – –
3 P. FOS 2007 115,577 DWT Sasebo Heavy Industries Co. Ltd Spot – – –
4 P. KIKUMA 2007 115,915 DWT Samsung Heavy Industries Co Ltd., Geoje, South Korea Spot – – –
5 P. YANBU 2011 105,391 DWT Sumitomo Heavy Industries Marine & Engineering Co., LTD. Spot – – –
* Total commission paid to third parties.
** Range of redelivery dates, with the actual date of redelivery being at the Charterers’ option, but subject to the terms, conditions, and exceptions of the particular charterparty.

About the Company

Performance Shipping Inc. is a global provider of shipping transportation services through its ownership of Aframax tankers. The Company’s current fleet is employed primarily in the spot market, and in some cases, on short to medium-term time charters, with leading energy companies and traders.

Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include, but are not limited to, statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.

The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect,” “pending,” and similar expressions, terms or phrases may identify forward-looking statements.

The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections.

In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies, fluctuations in currencies and interest rates, general market conditions, including fluctuations in charter hire rates and vessel values, changes in demand for our vessels, changes in the supply of vessels, changes in worldwide oil production and consumption and storage, changes in our operating expenses, including bunker prices, crew costs, dry-docking and insurance costs, our future operating or financial results, availability of financing and refinancing, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, the length and severity of epidemics and pandemics, including the ongoing outbreak of the novel coronavirus (COVID-19) and its impact on the demand for seaborne transportation of petroleum and other types of products, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions or events, including “trade wars”, acts by terrorists or acts of piracy on ocean-going vessels, potential disruption of shipping routes due to accidents, labor disputes or political events, vessel breakdowns and instances of off-hires and other important factors. Please see our filings with the U.S. Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties.

Disclaimer

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

(See financial tables attached)

PERFORMANCE SHIPPING INC.

FINANCIAL TABLES
Expressed in thousands of U.S. Dollars, except for share and per share data

CONSOLIDATED STATEMENTS OF OPERATIONS (CONTINUING AND DISCONTINUED OPERATIONS)

      For the three months ended December 31,   For the years ended December 31,
      2020     2019     2020     2019  
REVENUES:   (unaudited)   (unaudited)   (unaudited)    
  Voyage and time charter revenues $ 7,205   $ 10,580   $ 46,283   $ 26,846  
                   
EXPENSES:                
  Voyage expenses   3,311     2,083     14,622     3,447  
  Vessel operating expenses   2,412     2,605     11,544     11,321  
  Depreciation and amortization of deferred charges   1,631     891     5,898     3,684  
  Management fees       100     347     147  
  General and administrative expenses   1,858     2,733     7,985     8,162  
  Impairment losses       13,934     339     31,629  
  (Gain) / loss on vessels’ sale       127     (319 )   127  
  Provision for doubtful receivables   (73 )       79      
  Foreign currency (gains) / losses   7     10     32     (7 )
  Operating income / (loss) $ (1,941 ) $ (11,903 ) $ 5,756   $ (31,664 )
                   
OTHER INCOME / (EXPENSES):                
  Interest and finance costs   (619 )   (398 )   (2,089 )   (651 )
  Interest income   12     73     110     258  
  Total other expenses, net $ (607 ) $ (325 ) $ (1,979 ) $ (393 )
                   
Net income / (loss) $ (2,548 ) $ (12,228 ) $ 3,777   $ (32,057 )
                   
Gain from repurchase of preferred shares           1,500      
Income allocated to participating securities           (87 )    
                   
Net income / (loss) attributable to common stockholders $ (2,548 ) $ (12,228 )   5,190     (32,057 )
                   
Earnings / (Loss) per common share, basic * $ (0.51 ) $ (3.17 ) $ 1.06   $ (11.19 )
                   
Earnings / (Loss) per common share, diluted * $ (0.51 ) $ (3.17 ) $ 1.05   $ (11.19 )
                   
Weighted average number of common shares, *   4,966,210     3,854,802     4,875,475     2,864,676  
                   
Weighted average number of common shares, *   4,966,210     3,854,802     4,945,562     2,864,676  
* Comparative figures were adjusted to give effect to the reverse stock split that became effective on November 2, 2020.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME / (LOSS)

                   
      For the three months ended December 31,   For the years ended December 31,
      2020     2019     2020     2019  
      (unaudited)   (unaudited)   (unaudited)    
Net income / (loss) $ (2,548 ) $ (12,228 ) $ 3,777   $ (32,057 )
Other comprehensive income / (loss) (Actuarial gain/ (loss))   (61 )   12     (61 )   12  
                   
Comprehensive income/ (loss) $ (2,609 ) $ (12,216 ) $ 3,716   $ (32,045 )
                   

CONDENSED CONSOLIDATED BALANCE SHEET DATA    
(Expressed in thousands of US Dollars)    
      December 31, 2020   December 31, 2019**

ASSETS
  (unaudited)    
           
Cash and cash equivalents $ 21,378 $ 26,363
Advances for vessel acquisitions and other vessels’ costs     11,017
Vessels, net   128,108   82,871
Other fixed assets, net   1,135   993
Other assets   7,233   9,325
  Total assets $ 157,854 $ 130,569
           

LIABILITIES AND STOCKHOLDERS’ EQUITY
       
           
Long-term debt, net of unamortized deferred financing costs $ 57,666 $ 32,283
Other liabilities   3,391   4,048
Total stockholders’ equity   96,797   94,238
  Total liabilities and stockholders’ equity $ 157,854 $ 130,569
           
**The balance sheet data as of December 31, 2019 has been derived from the audited consolidated financial statements at that date.

OTHER FINANCIAL DATA (CONTINUING AND DISCONTINUED OPERATIONS)        
                   
      For the three months ended December 31,   For the years ended December 31,
      2020     2019     2020     2019  
      (unaudited)   (unaudited)   (unaudited)    
Net Cash provided by / (used in) Operating Activities $ 881   $ (305 ) $ 13,176   $ (4,194 )
Net Cash provided by / (used in) Investing Activities $ (22,235 ) $ 3,188   $ (40,146 ) $ (18,517 )
Net Cash provided by Financing Activities $ 5,544   $ 15,981   $ 21,985   $ 38,581  

Dividend Policy – Quarterly Calculations

Our Board of Directors has adopted a variable quarterly dividend policy, pursuant to which we may declare and pay a variable quarterly cash dividend. If declared, the quarterly dividend is expected to be paid each February, May, August and November and will be equal to available cash from operations during the previous quarter after cash payments for debt repayment and interest expense and reserves for the replacement of our vessels, scheduled drydockings, intermediate and special surveys and other purposes as our Board of Directors may from time to time determine are required, after taking into account contingent liabilities, the terms of any credit facility, our growth strategy and other cash needs as well as the requirements of Marshall Islands law. The declaration and payment of dividends is, at all times, subject to the discretion of our Board of Directors. Our Board of Directors may review and amend our dividend policy from time to time, in light of our plans for future growth and other factors.

In accordance with our dividend policy, and taking into account the above-listed factors, we expect to pay dividends only if during the preceding quarter Quarterly Cash Flow is positive and Quarter-End Excess Cash is also positive. As a general guideline, the amount of any such dividends is expected to be based on a pay-out ratio of the lower of i) Quarterly Cash Flow; and ii) Quarter-End Excess Cash. So long as our end of quarter outstanding debt exceeds our equity market capitalization our pay-out ratio is expected to be 50%. We will consider increasing the pay-out ratio gradually up to a maximum level of 90% that we may achieve when our end of quarter outstanding debt is less than 10% of our equity market capitalization. Quarter-End Excess Cash is defined as actual end of quarter Cash and Cash Equivalents over our Minimum Cash Threshold. Minimum Cash Threshold is defined as the sum of minimum liquidity pursuant to our loan agreements and $1.5 million per vessel. Our bank facilities currently require us to maintain minimum liquidity of $9.0 million.

Quarterly Cash Flow is equal to voyage and time charter revenues less voyage expenses, less vessel operating expenses, less general and administrative expenses, less – the greater of i) net interest expense and repayment of long-term bank debt or ii) fleet replacement reserves – and less maintenance reserves for our fleet.

We believe the above approach will ensure the sustainability of our Company and replacement of our fleet as during quarters where either Excess Cash is negative or Quarterly Cash Flow is negative, we will not pay dividends until Quarterly Cash Flow is positive and Excess Cash is also positive. Below are our calculations of Quarter-End Excess Cash and Quarterly Cash Flow for the fourth quarter of 2020.

DIVIDEND CALCULATIONS
(Expressed in thousands of U.S. Dollars)
      For the three months ended December 31, 2020
  Voyage and time charter revenues $ 7,205  
  Less, Voyage expenses $ (3,311 )
  Less, Vessel operating expenses $ (2,412 )
  Less, General and administrative expenses $ (1,668 )
       
 
Less, Greater of (I) or (II):
   
  Interest and finance costs $ (619 )
  Plus, Repayment of long-term bank debt $ (2,453 )
  Total (I) $ (3,072 )
 
Or
   
  Replacement reserve (II) $ (1,714 )
       
  Less, Maintenance reserve   (438 )
Quarterly Cash Flow (A) $ (3,696 )
       
  Cash and cash equivalents $ 21,378  
  Less, Minimum Cash Threshold $ 16,500  
Quarter-End Excess Cash (B) $ 4,878  
       
Quarterly Cash Flow Test (A) >0, AND   Not eligible for dividend
Quarter-End Excess Cash Test (B) >0   Eligible for dividend
Cash Available for Dividend, lower (A) or (B) $  
  Payout ratio   50 %
Quarterly Dividend $  
       

(1) General and administrative expenses, for the purpose of calculating dividends, exclude non-cash items.
(2) Replacement reserves reflect the aggregate annual amount of cash that the Company retains to fund the replacement of each of its vessels. In addition to the replacement reserve retained and reinvested at a certain annual rate or equivalent debt repayment, the Company estimates at the specific expected replacement date to utilize funds from the proceeds of the scrap value of the vessels and the assumption of a modest level of debt to purchase the replacement vessel assuming such replacement is for a ten-year-old vessel at the ten-year historical mid-cycle value.
(3) Maintenance reserves are based on an estimated cost for the drydock, intermediate and special surveys of the vessels in our fleet over the recurring statutory five-year survey period. They are used, instead of actual maintenance costs when incurred, for purposes of calculating the quarterly dividend to remove the additional cash flow variability during quarters that drydocks occur. 



Corporate Contact:
Andreas Michalopoulos
Chief Executive Officer, Director and Secretary
Telephone: + 30-216-600-2400
Email: [email protected]
Website: www.pshipping.com

Investor and Media Relations:
Edward Nebb
Comm-Counsellors, LLC
Telephone: + 1-203-972-8350
Email: [email protected]

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Re-Opening of the Lead Plaintiff Process in Class Action Lawsuit Against Nutanix, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Re-Opening of the Lead Plaintiff Process in Class Action Lawsuit Against Nutanix, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the re-opening of the lead plaintiff process in the class action lawsuit against Nutanix, Inc. (“Nutanix” or “the Company”) (NASDAQ: NTNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between March 1, 2018 and May 30, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before March 22, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Nutanix misled investors about the health of its sales pipeline, customer base, and sales productivity. The truth of the poor state of the Company’s sales prospects was partially revealed over the course of time, causing shares to tumble. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Nutanix, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo

IIROC Trade Resumption – LABS.WT

Canada NewsWire

TORONTO, March 5, 2021 /CNW/ – Trading resumes in:

Company: MediPharm Labs Corp.

TSX Symbol: LABS.WT

All Issues: No

Resumption (ET): 9:30 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

PG&E Self-Reports Small Number of Missed Inspections to CPUC; Takes Immediate Corrective Actions to Ensure Safe Operations

PG&E Self-Reports Small Number of Missed Inspections to CPUC; Takes Immediate Corrective Actions to Ensure Safe Operations

Updated Inspections to be Complete by March 31, 2021

SAN FRANCISCO–(BUSINESS WIRE)–
Yesterday, Pacific Gas and Electric Company (PG&E) informed the California Public Utilities Commission (CPUC) about an error that it is actively working to correct on an expedited basis, related to its System Inspection Program that is part of its Community Wildfire Safety Program.

PG&E’s System Inspection Program examines its electric distribution, transmission and substation equipment across its service area in Northern and Central California to find and fix potential risks to the safety and reliability of the system. In both 2019 and 2020 this included enhanced inspections of PG&E electric transmission, distribution and substation assets located in Tier 3 (extreme) and Tier 2 (elevated) High Fire-Threat Districts (HFTDs).

PG&E has determined that it did not do enhanced inspections on 24 Tier 3 hydroelectric substations in 2020, and five distribution poles in 2019 and 2020.

Although these assets make up a small percentage – less than 0.01 percent of the approximately 50,000 electric transmission structures, approximately 700,000 distribution poles and 222 substations subject to rigorous inspection under the company’s Wildfire Mitigation Plans, missing them falls short of the company’s commitment to inspect these assets. PG&E is taking immediate action to inspect these facilities by March 13 for Tier 3, and March 31 for Tier 2 facilities. PG&E is completing any high-priority repairs on assets in both tiers expeditiously.

“While these missed inspections are a small percentage in comparison to all the work accomplished in 2019 and 2020, we have to make sure that all of our work is executed and recorded accurately every time. This must be our new standard going forward. The safety of our customers, communities and workforce is our most important responsibility and no one will watch us more closely than we will watch ourselves. We expect to have these issues mitigated by the end of March and will share results of our root cause evaluation,” said Adam Wright, Executive Vice President and Chief Operating Officer.

PG&E is taking this matter seriously and is implementing immediate steps to correct it. The corrective action plan includes:

  • Self-reporting this matter to the CPUC, the federal monitor overseeing our probation, Governor’s Office Operational Observer and other key stakeholders.
  • Conducting a root cause evaluation to determine process breakdowns and taking immediate corrective actions to meet our regulatory requirements and safety commitments.
  • Completing the necessary inspections by March 13 in Tier 3, and by March 31 in Tier 2, and completing any high-priority repairs on assets in both tiers expeditiously.
  • Performing enhanced inspections on these facilities in compliance with our 2021 WMP.
  • Updating our records so that our enhanced inspection program is current going forward.

The company will share its findings and progress in addressing these issues with the CPUC so that they do not reoccur.

About PG&E

Pacific Gas and Electric Company, a subsidiary of PG&E Corporation (NYSE:PCG), is a combined natural gas and electric utility serving more than 16 million people across 70,000 square miles in Northern and Central California. For more information, visit www.pge.com and www.pge.com/news.

Forward-Looking Statement

This press release contains forward-looking statements that are not historical facts, including statements about the beliefs, expectations, estimates, future plans and strategies of PG&E, including but not limited to statements regarding the impact of the PG&E’s notification to the California Public Utilities Commission and the expected timing of remedial inspections. These statements are based on current expectations and assumptions, which management believes are reasonable, and on information currently available to management, but are necessarily subject to various risks and uncertainties. In addition to the risk that these assumptions prove to be inaccurate, factors that could cause actual results to differ materially from those contemplated by the forward-looking statements include factors disclosed in PG&E Corporation’s and PG&E’s joint annual report on Form 10-K for the year ended December 31, 2020, and other reports filed with the Securities and Exchange Commission, which are available on PG&E Corporation’s website at www.pgecorp.com and on the SEC website at www.sec.gov. PG&E Corporation and PG&E undertake no obligation to publicly update or revise any forward-looking statements, whether due to new information, future events or otherwise, except to the extent required by law.

Media Relations

415.973.5930

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Utilities Energy

MEDIA:

Boxlight MimioSTEM Division Details Successful Integration for High School

Boxlight MimioSTEM Division Details Successful Integration for High School

LAWRENCEVILLE, Ga.–(BUSINESS WIRE)–Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage, and software solutions, today announced the outstanding integration of the Robo 3D printer for Montana students.

Robo 3D printers have successfully been incorporated into a district’s STEM instruction because of its simplicity and ready-to-use curriculum. With every Robo 3D printer purchase, educators also have access to the multi-award winning MyStemKits standards-aligned curriculum for grades K-12.

Shelley Emslie, a 5th grade teacher in Bigfork, Montana, was interested in technology that would boost her students’ creativity, as well as strengthen their critical thinking and problem-solving skills. She feels that with 3D printer technology, her students have exceeded expectations.

“The world is not 2D. We are equipping our students to complete, excel, and succeed in a 3D world. We use Robo 3D printers daily and they inspire creativity, critical thinking, and problem solving.”

For a full case study about this successful integration, please visit Boxlight.

About Boxlight Corporation

Boxlight Corporation (Nasdaq: BOXL) (“Boxlight”) is a leading provider of interactive technology solutions under its award-winning brands Clevertouch® and Mimio®. The company aims to improve engagement and communication in diverse business and education environments. Boxlight develops, sells, and services its integrated solution suite including interactive displays, collaboration software, supporting accessories and professional services. For more information about the Boxlight story, visit http://www.boxlight.com and Clevertouch, https://www.clevertouch.com/.

Forward Looking Statements

This press release may contain information about Boxlight’s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements because of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to maintain and grow its business, variability of operating results, its development and introduction of new products and services, marketing and other business development initiatives, competition in the industry, etc. Boxlight encourages you to review other factors that may affect its future results in Boxlight’s filings with the Securities and Exchange Commission.

Media

Sunshine Nance

+1 360-464-2119 x254

[email protected]

Investor Relations

+1 360-464-4478

[email protected]

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: Hardware Technology Primary/Secondary Software Education

MEDIA:

II-VI Incorporated Presents New Product and Technology Capabilities at Photonics West and BiOS Digital Marketplace 2021

PITTSBURGH, March 05, 2021 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq: IIVI), a global leader in engineered materials and optoelectronic components, today announced that it will showcase its broad portfolio of product and technology innovations at the upcoming SPIE Photonics West Digital Forum and BiOS Digital Marketplace, March 6-11. These products and capabilities are enabling next-generation photonics applications in diverse markets such as materials processing, life sciences, automotive, consumer electronics, communications, and more. Traditionally held in San Francisco, this year’s event will be fully virtual.

Recent new product introductions announced by II-VI include the following:

  • 1060 nm seed laser in a 3-pin miniature package for pulsed fiber lasers.
  • Ceramic YAG (yttrium aluminum garnet) technology platform for solid-state lasers.
  • Double-junction vertical cavity surface-emitting laser (VCSEL) arrays.
  • VCSEL flood illuminator modules for in-cabin monitoring in automotive.
  • Multi-wavelength laser module product line for life sciences.
  • Diffraction-limited apochromatic objective lenses for fluorescence imaging.

During the event, registered attendees will have the opportunity to interact online with company representatives to learn about new products and watch video demonstrations, including the latest WaveShaper® test instrument designed for optical R&D and production test applications.

II-VI will participate in a special industry event focused on the business side of photonics: Dr. Julie Sheridan Eng, Senior Vice President and General Manager, Optoelectronic and RF Devices Business Unit, will present at the “Applications of sensing and imaging solutions” session on Thursday, March 11, at 10:00 a.m. PT.

II-VI will also participate in these upcoming industry events as it celebrates its 50-year golden anniversary in 2021:

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.

CONTACT:  Mark Lourie
Vice President, Corporate Communications
[email protected] 
www.ii-vi.com/contact-us



Chicken Soup for the Soul Entertainment to Participate in D.A. Davidson Consumer Growth Virtual Conference

COS COB, Conn., March 05, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced that Bill Rouhana, Chief Executive Officer, will attend the D.A. Davidson Consumer Growth Virtual Conference on Thursday, March 11, 2021, and conduct virtual one-on-one and small group meetings throughout the day. Mr. Rouhana is also scheduled to participate in a fireside chat at 11 a.m. Eastern Time and will serve on a panel at 3 p.m. Eastern Time to discuss “Has the Over-The-Top (OTT) Video Market Reached a Tipping Point?” A live webcast, as well as a replay, of the fireside chat will be available on the company’s investor relations website at https://ir.cssentertainment.com/.

ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENT

Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) operates streaming video-on-demand networks (VOD). The company owns Crackle Plus, which owns and operates a variety of ad-supported and subscription-based VOD networks including Crackle, Popcornflix, Popcornflix Kids, Truli, Pivotshare, Españolflix and FrightPix. The company also acquires and distributes video content through its Screen Media subsidiary and produces original long and short-form content through Landmark Studio Group, its Chicken Soup for the Soul Originals division and APlus.com. Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the Soul, LLC, which publishes the famous book series and produces super-premium pet food under the Chicken Soup for the Soul brand name.

FORWARD-LOOKING STATEMENTS

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks (including those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the nine-month period ended September 30, 2020) and uncertainties which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Investors should realize that if our underlying assumptions for the projections contained herein prove inaccurate or that known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections.

INVESTOR RELATIONS MEDIA CONTACT
Taylor Krafchik Kate Barrette
Ellipsis RooneyPartners LLC
[email protected] [email protected]
(646) 776-0886 (212) 223-0561



22nd Century Group to Participate in Investor Conferences in March 2021

WILLIAMSVILLE, N.Y., March 05, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that members of its management team will participate in three investor conferences during March 2021.

Institutional investors and those invited to attend these virtual conference events may request one-on-one meetings with representatives of the Company through the respective conference hosts or by contacting 22nd Century Group’s investor relations via [email protected].

Events 22nd Century Group will participate in include:

The DA Davidson 4th Annual Consumer Growth Conference, March 11, 2021

One-on-one meetings will be available on the afternoon of Thursday, March 11. To request a meeting, please contact your DA Davidson sales representative.

The 33rd Annual Roth Conference, March 15-17, 2021

One-on-one and small group meetings will be available on Tuesday, March 16. Additional times may be available to accommodate meeting requests as needed. To request a meeting, please contact your Roth sales representative.

The Investor Summit Virtual Conference, March 23-25, 2021

James A. Mish, chief executive officer of 22nd Century, will provide an overview presentation of the Company. An audio webcast of the presentation will be available through 22nd Century’s Events web page in the Company’s Investor Relations section of the website, at www.xxiicentury.com/investors/events. One-on-one meetings will be available on Tuesday, March 23. To request a meeting, please contact your Investor Summit Group representative.

About 22nd Century Group, Inc.

22nd Century Group, Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century’s primary mission in tobacco is to reduce the harm caused by smoking through the Company’s proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes. The Company’s primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.

Learn more at xxiicentury.com, on Twitter @_xxiicentury, and on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 11, 2020, and in its subsequently filed Quarterly Report on Form 10-Q. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact:

Mei Kuo
Director, Communications & Investor Relations
22nd Century Group, Inc.
(716) 300-1221
[email protected]